false
Skip Navigation Links
Home
About SSO
ASO Article Search
COVID-19 Resources
SSO Website
Menu
Home
About SSO
ASO Article Search
COVID-19 Resources
SSO Website
Hamburger Menu
Catalog
FDA 101 for Surgical Oncologists: Intro to FDA and ...
FDA 101 for Surgical Oncologists: Intro to FDA and the Center for Biologics Evaluation and Research (CBER) (2022 Webinar)
Activity Overview
Join SSO for a free webinar two part series featuring faculty from the FDA. Learn about the Food and Drug Administration (FDA) and its role in surgical oncology as it relates to biologics. Find out what FDA regulates, what an approval means, and key regulatory approaches. Learn about the Center for Biologics Evaluation and Research (CBER) and regulatory perspectives on cell and gene based cancer therapies. Participants will be provided with information on resources available from FDA.
Faculty
Adnan Jaigirdar, MD, FDA CBER
Gautam Mehta, MD, FDA CDER
Genevieve Boland, MD, PhD, SSO
Darren Carpizo, MD, PhD, SSO
Part two of the series
will take place on Thursday, September 8 at Thursday, 5 PM ET, with a focus on the Food and Drug Administration (FDA) and its role in surgical oncology as it relates to drugs. Participants will learn about investigational new drug applications (INDs) and the Oncology Center of Excellence (OCE).
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
FDA 101 for Surgical Oncologists: Intro to FDA and the Center for Biologics Evaluation and Research (CBER) (2022 Webinar) Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Forgot Password
×
Please select your language
1
English